0001209191-18-057432.txt : 20181106 0001209191-18-057432.hdr.sgml : 20181106 20181106170156 ACCESSION NUMBER: 0001209191-18-057432 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181102 FILED AS OF DATE: 20181106 DATE AS OF CHANGE: 20181106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RAGUSA ROBERT P CENTRAL INDEX KEY: 0001222644 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38720 FILM NUMBER: 181163831 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Twist Bioscience Corp CENTRAL INDEX KEY: 0001581280 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 462058888 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH, SUITE 5 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 800-719-0671 MAIL ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH, SUITE 5 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-11-02 0 0001581280 Twist Bioscience Corp TWST 0001222644 RAGUSA ROBERT P C/O TWIST BIOSCIENCE CORPORATION 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 1 0 0 0 Common Stock 2018-11-02 4 C 0 542203 A 542203 I By Illumina, Inc. Common Stock 2018-11-02 4 C 0 329305 A 871508 I By Illumina, Inc. Common Stock 2018-11-02 4 C 0 673378 A 1544886 I By Illumina, Inc. Common Stock 2018-11-02 4 C 0 157215 A 1702101 I By Illumina, Inc. Common Stock 0 D Series A Preferred Stock 2018-11-02 4 C 0 542203 0.00 D Common Stock 542203 0 I By Illumina, Inc. Series B Preferred Stock 2018-11-02 4 C 0 329305 0.00 D Common Stock 329305 0 I By Illumina, Inc. Series C Preferred Stock 2018-11-02 4 C 0 673378 0.00 D Common Stock 673378 0 I By Illumina, Inc. Series D Preferred Stock 2018-11-02 4 C 0 157215 0.00 D Common Stock 157215 0 I By Illumina, Inc. The Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock have no expiration date and converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering. The Reporting Person is the Senior Vice President, Global Quality and Operations of Illumina, Inc. and has sole voting and dispositive power over the shares held of record by Illumina, Inc. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. /s/ William Solis, as Attorney-in-Fact 2018-11-06